Therapeutic Apheresis and Dialysis最新文献_第2页

Factors affecting clinical outcomes of continuous and intermittent plasmapheresis in patients with severe hypertriglyceridemia 影响严重高甘油三酯血症患者连续性和间歇性浆膜腔穿刺术临床疗效的因素

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-04-27 DOI: 10.1111/1744-9987.14134

Eiman A. Hussein

{"title":"Factors affecting clinical outcomes of continuous and intermittent plasmapheresis in patients with severe hypertriglyceridemia","authors":"Eiman A. Hussein","doi":"10.1111/1744-9987.14134","DOIUrl":"https://doi.org/10.1111/1744-9987.14134","url":null,"abstract":"IntroductionAcute hypertriglyceridemia is considered a category III indication for plasmapheresis. The use of plasma as replacement fluid (RF) has been suggested to replace the consumed lipoprotein lipase. Heparin when used as an anticoagulant could possibly release lipoprotein lipase, thereby increasing triglyceride clearance.MethodsThe impact of RF (albumin vs fresh frozen plasma (FFP) and anticoagulant (ACD‐A vs. heparin) on triglycerides following plasmapheresis in 27 patients with severe hypertriglyceridemia (SHTG) was investigated. A paired study of four patients with recurrent SHTG was conducted, evaluating continuous (Optia) versus intermittent flow plasmapheresis (Haemonetics).ResultsShorter procedures positively impacted triglycerides (TG) drop post‐sessions p < 0.05. In albumin sessions, patients who used heparin demonstrated significantly greater drop in TG and required less sessions than did those with citrate p < 0.05. In heparin sessions, patients who used albumin demonstrated significantly greater drop in triglycerides and required less sessions than did those with FFP p < 0.05. Three of six patients who used FFP and heparin showed a triglyceride drop of 11.7% following three sessions and a 50% drop with one albumin session. Compared with Haemonetics, Optia removed comparable volumes of plasma in less time, processing smaller blood volumes and using less citrate p < 0.05. Patients demonstrated significantly lower drop in TG and required more sessions with Haemonetics than they did with Optia p < 0.05.ConclusionShorter procedure was the main predictor for effective TG clearance. This can be achieved by continuous apheresis technology, particularly when using albumin as RF. TG removal via Optia seems to be optimized by using heparin.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"41 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A scale development study: Primary Caregiver Burden Scale Individuals Receiving Hemodialysis Treatment 量表开发研究：接受血液透析治疗的患者主要护理者负担量表

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-04-27 DOI: 10.1111/1744-9987.14129

Cansu Kosar Sahin, Hatice Ceylan, Canan Demir Barutcu

{"title":"A scale development study: Primary Caregiver Burden Scale Individuals Receiving Hemodialysis Treatment","authors":"Cansu Kosar Sahin, Hatice Ceylan, Canan Demir Barutcu","doi":"10.1111/1744-9987.14129","DOIUrl":"https://doi.org/10.1111/1744-9987.14129","url":null,"abstract":"IntroductionAs hemodialysis is a long‐term treatment method requiring significant self‐management skills, it affects both the patient and the caregiver in many ways. It is inevitable that changes in the burden perceived by the caregiver over time will not affect the patient's health care outcomes. The aim of this study was to develop an up‐to‐date scale by examining the psychometric properties of items created specifically for the care burden perceived by individuals who provide care for patients receiving hemodialysis treatment.MethodsThis study is a methodological study with the use of the COSMIN Checklist. The sample of the study included 404 individuals who were the primary caregivers of patients receiving hemodialysis treatment. Data were collected using descriptive characteristics form and the draft form of the Primary Caregiver Burden Scale Individuals Receiving Hemodialysis Treatment. Exploratory and confirmatory factor analysis and predictive validity were used to evaluate validity. The Cronbach's alpha reliability coefficient, item analysis, and test–retest method were employed to evaluate reliability.ResultsAccording to exploratory factor analysis, a scale structure with four subdimensions was determined, and goodness of fit was achieved using confirmatory factor analysis. The Cronbach's alpha coefficient of the final form of the scale consisting of 34 items was found to be 0.95 for the total scale, 0.93 for the self‐management support subscale, 0.91 for the psychological support subscale, 0.91 for the caregiver symptom subscale, and 0.93 for the caregiver individual coping subscale.ConclusionThe Primary Caregiver Burden Scale Individuals Receiving Hemodialysis Treatment, which was found to meet the validity and reliability criteria, has a four‐point Likert‐type scoring structure, 34 items, and four subdimensions. It is thought that the scale can make significant contributions to the international literature if its validity and reliability are established with nursing practices and research.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"23 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Post‐COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients 埃及血液透析患者在 COVID 后的焦虑、抑郁和生活质量

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-04-17 DOI: 10.1111/1744-9987.14128

Rehab AlSayed Shaban, Ahmed E. Abdulgalil, Ahmed Bahie

引用次数: 0

Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients 介质截流膜对不受控制的糖尿病血液透析患者体内喷托苷和 N-（羧甲基）赖氨酸水平的影响

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-04-04 DOI: 10.1111/1744-9987.14126

Neriman Sıla Koç, Hasan Yeter, Tolga Yıldırım, Yunus Erdem, Rahmi Yılmaz

{"title":"Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients","authors":"Neriman Sıla Koç, Hasan Yeter, Tolga Yıldırım, Yunus Erdem, Rahmi Yılmaz","doi":"10.1111/1744-9987.14126","DOIUrl":"https://doi.org/10.1111/1744-9987.14126","url":null,"abstract":"IntroductionPatients on hemodialysis, especially with diabetes, face elevated cardiovascular events. A major contributor to complications associated with diabetes is advanced glycation end products (AGEs). Removing these compounds is challenging in traditional hemodialysis. Medium‐cut‐off (MCO) membranes potentially remove toxins without significant albumin loss. This study explored how MCO membranes impact AGEs levels in uncontrolled diabetic patients undergoing hemodialysis.MethodsSixteen patients received MCO membrane dialysis, while others used high‐flux (HF) membranes. After 12 sessions, the dialyzers were switched, totaling 24 sessions. Blood samples at trial initiation (T0), session 12 (T1) and session 24 (T2) tested for CML, Pentosidine, laboratory parameters.ResultsSwitching dialyzers showed increased albumin with MCO‐to‐HF and decreased with HF‐to‐MCO, albeit nonsignificant (p = 0.5/p = 0.1). Patients on MCO had lower albumin levels than HF (p = 0.03/p = 0.6, respectively). Hemodialysis with MCO demonstrated lower levels of CML/Pentosidine compared to HF (p = 0.09/p = 0.9 for CML; p = 0.04/p = 0.3 for Pentosidine). Transitioning to HF led to elevated levels (p = 0.4/p = 0.09 for CML; p = 0.3/p = 0.07 for Pentosidine).ConclusionMCO dialysis in diabetic individuals notably reduces AGE levels.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"18 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140577033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Active vitamin D analog and SARS-CoV-2 IgG after BNT162b2 vaccination in patients with hemodialysis 血液透析患者接种 BNT162b2 疫苗后的活性维生素 D 类似物和 SARS-CoV-2 IgG

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-03-19 DOI: 10.1111/1744-9987.14121

Akio Nakashima, Izumi Yamamoto, Arisa Kobayashi, Keita Kimura, Tatsuhiro Yaginuma, Shinichiro Nishio, Kazuhiko Kato, Rena Kawai, Tetsuya Horino, Ichiro Ohkido, Takashi Yokoo

引用次数: 0

Therapeutic Apheresis and Dialysis Forthcoming Events April 2024 治疗性血液透析 2024 年 4 月即将举办的活动

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-03-04 DOI: 10.1111/1744-9987.14009

引用次数: 0

Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy. 直接作用抗病毒疗法时代的丙型肝炎透析患者管理。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-02-01 Epub Date: 2023-09-04 DOI: 10.1111/1744-9987.14060

Michel Jadoul, Laura Labriola

引用次数: 0

The effect of double filtration plasmapheresis and corticosteroids on patients with anti-dipeptidyl-peptidase-like protein 6 encephalitis. 抗二肽基肽酶样蛋白 6 脑炎患者接受双滤过性浆细胞清除术和皮质类固醇的效果。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-02-01 Epub Date: 2023-07-17 DOI: 10.1111/1744-9987.14039

Wenbin Wan, Yuanmei Pan, Ying Chen, Shuwei Bai, Xiaoying Yao, Yan Lin, Jun Wu, Liping Ni, Yufang Mei, Huiying Qiu, Yan Zhou, Yong Hao, Yangtai Guan

{"title":"The effect of double filtration plasmapheresis and corticosteroids on patients with anti-dipeptidyl-peptidase-like protein 6 encephalitis.","authors":"Wenbin Wan, Yuanmei Pan, Ying Chen, Shuwei Bai, Xiaoying Yao, Yan Lin, Jun Wu, Liping Ni, Yufang Mei, Huiying Qiu, Yan Zhou, Yong Hao, Yangtai Guan","doi":"10.1111/1744-9987.14039","DOIUrl":"10.1111/1744-9987.14039","url":null,"abstract":"Introduction: Anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis is a rare condition with varied symptoms including gastrointestinal issues, weight loss, cognitive and mental dysfunction, and hyperexcitability of the central nervous system.Methods: We studied five patients with anti-DPPX encephalitis who received immunotherapy, specifically DFPP, at our hospital. We analyzed their clinical symptoms, lab results, electrophysiological and imaging findings, and outcomes with immunotherapy.Results: Patients presented with cognitive dysfunction, tremor, seizures, psychiatric disturbances, and cerebellar and brainstem dysfunction. Magnetic resonance imaging (MRI) showed brain abnormalities in one patient and elevated cerebrospinal fluid (CSF) protein levels in two patients. Antibodies against DPPX were detected in all patients and in CSF in two patients. One patient had antibodies against anti-CV2/contactin response mediator protein 5 (CRMP5). All patients responded well to DFPP and corticosteroids.Conclusion: DFPP may be an effective treatment for anti-DPPX encephalitis. Further research is needed to understand disease progression and evaluate immunotherapy efficacy.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"141-151"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9827462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A nephrologist dream of peritoneal dialysis catheter with zero migration: A multicenter prospective study. 肾脏病学家梦寐以求的零移位腹膜透析导管：一项多中心前瞻性研究。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-02-01 Epub Date: 2023-08-16 DOI: 10.1111/1744-9987.14045

Abdullah K Al-Hwiesh, Ibrahiem Saeed Abdul-Rahman, Jose Carolino Divino-Filho, Mohamed A Nasreldin, Amani A Al-Hwiesh, Nadia Al-Audah, Hatem H Althubaini, Moaz Abdulgalil, Ghassan A Salah, Mohammad Z Al-Baggal, Bassam A Abu-Oun, Nehad Al-Audah, Habib S Al-Ramadan, Kaltham Alfalah, Zahra Almarri, Ayat A Al-Awal

{"title":"A nephrologist dream of peritoneal dialysis catheter with zero migration: A multicenter prospective study.","authors":"Abdullah K Al-Hwiesh, Ibrahiem Saeed Abdul-Rahman, Jose Carolino Divino-Filho, Mohamed A Nasreldin, Amani A Al-Hwiesh, Nadia Al-Audah, Hatem H Althubaini, Moaz Abdulgalil, Ghassan A Salah, Mohammad Z Al-Baggal, Bassam A Abu-Oun, Nehad Al-Audah, Habib S Al-Ramadan, Kaltham Alfalah, Zahra Almarri, Ayat A Al-Awal","doi":"10.1111/1744-9987.14045","DOIUrl":"10.1111/1744-9987.14045","url":null,"abstract":"Introduction: PD catheter tip migration is a common complication and a significant cause of catheter malfunction. In this perspective, we present our experience with a new catheter and a new technique that involves the use of a new triple cuff PD catheter and a low entry site in an attempt to prevent PD catheter migration.Methods: A total of 503 incident PD patients have been studied in more than one PD center over a period of 5 years.Results: During the 5-year follow up we recorded zero percent catheter migration. Other technical complications were poor drainage in 3.4%, omental wrap in 2.8%, early leakage in 3.4%, and catheter replacement in 2.4%. By the end of the study, the one-year PD catheter survival was 97.6%.Conclusion: Our new triple cuff PD catheter and our low-entry approach seem to be effective in preventing PD catheter migration and minimizing other mechanical complications.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"89-95"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10381120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diuretics or ultrafiltration in the treatment of acute decompensated heart failure: An updated systematic review and meta-analysis. 治疗急性失代偿性心力衰竭的利尿剂或超滤疗法：最新系统综述和荟萃分析。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2024-02-01 Epub Date: 2023-07-19 DOI: 10.1111/1744-9987.14037

Vasileios Terpos, Stefanos Roumeliotis, Panagiotis I Georgianos, Eleni Papa, Dimitrios G Tsalikakis, Evangelos Papachristou, Vassilios Liakopoulos

{"title":"Diuretics or ultrafiltration in the treatment of acute decompensated heart failure: An updated systematic review and meta-analysis.","authors":"Vasileios Terpos, Stefanos Roumeliotis, Panagiotis I Georgianos, Eleni Papa, Dimitrios G Tsalikakis, Evangelos Papachristou, Vassilios Liakopoulos","doi":"10.1111/1744-9987.14037","DOIUrl":"10.1111/1744-9987.14037","url":null,"abstract":"Introduction: Hospitalization for decompensated heart failure is a major public health issue.Methods: We performed a meta-analysis to summarize and analyze if there is a benefit in using ultrafiltration over diuretics in terms of reducing mortality or hospital readmissions, primarily and identified 10 randomized controlled trials (RCTs) including 941 patients.Results: Compared to diuretics, treatment with ultrafiltration was associated with a significant reduction in heart failure hospitalizations (risk ratio [RR]: 0.72; 95% confidence interval [CI]: 0.55-0.96, p = 0.02) and significant increase in weight and net fluid loss (mean difference [MD]: -1.55, CI: -2.36 to -0.74, p = 0.0002) and (MD: -2.10, CI: -3.32 to -0.89, p = 0.0007), respectively. There was no significant difference among treatments regarding the duration of hospitalization, the increase in serum creatinine levels, and mortality.Conclusion: Among patients with decompensated heart failure, compared to diuretics, ultrafiltration is associated with reduced rehospitalizations and increased weight/net fluid loss.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"9-22"},"PeriodicalIF":1.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9840394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0